Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Boston Scientific Corp (BSX) Insider Trading Activity

    Healthcare • Medical Devices • 48,000 employees

    Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

    Total Value

    -$53,725,456.91

    Total Shares

    -243,447

    Average Trade Value

    -$1,119,280.35

    Most Active Insider

    Mahoney Michael F

    Total Activity: $46,417,986

    Largest Single Transaction

    $13,573,743

    by Mahoney Michael F on Nov 5, 2024

    30-Day Activity

    4 Transactions

    Volume: 4,056 shares
    Value: $672,716

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Evp, Human Resources
    Officer
    Dec 2, 2024 6,983 $633,917 29,308 (-23.8%) Sale
    Evp, Human Resources
    Officer
    Dec 2, 2024 1,197 $29,386 36,291 (+3.3%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Dec 2, 2024 3,066 $52,919 35,094 (+8.7%) Exercise/Conversion
    Svp, Global Controller and Cao
    Officer
    Nov 27, 2024 1,336 $121,105 2,957 (-45.2%) Sale
    EVP Grp Pres, Medsurg Apac
    Officer
    Nov 25, 2024 1,009 $17,415 14,988 (+6.7%) Exercise/Conversion
    EVP Grp Pres, Medsurg Apac
    Officer
    Nov 25, 2024 14,010 $1,250,664 978 (-1432.5%) Sale
    EVP Grp Pres, Medsurg Apac
    Officer
    Nov 25, 2024 3,177 $72,150 13,979 (+22.7%) Exercise/Conversion
    Director
    Nov 21, 2024 4,877 $446,902 39,398 (-12.4%) Sale
    Evp, Global Operations
    Officer
    Nov 8, 2024 17,362 $426,237 70,286 (+24.7%) Exercise/Conversion
    Evp, Global Operations
    Officer
    Nov 8, 2024 30,580 $2,680,572 39,706 (-77.0%) Sale
    Chairman, President CEO
    Director, Officer
    Nov 5, 2024 56,211 $970,202 1,628,307 (+3.5%) Exercise/Conversion
    Chairman, President CEO
    Director, Officer
    Nov 5, 2024 55,676 $908,076 1,683,983 (+3.3%) Exercise/Conversion
    Chairman, President CEO
    Director, Officer
    Nov 5, 2024 2,596 $221,108 1,681,387 (-0.2%) Sale
    Chairman, President CEO
    Director, Officer
    Nov 5, 2024 160,182 $13,573,743 1,521,205 (-10.5%) Sale
    Evp, Human Resources
    Officer
    Nov 1, 2024 1,197 $29,386 39,011 (+3.1%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Nov 1, 2024 6,983 $588,876 32,028 (-21.8%) Sale
    Evp, Human Resources
    Officer
    Nov 1, 2024 3,066 $52,919 37,814 (+8.1%) Exercise/Conversion
    EVP Group Pres, Cardiology
    Officer
    Oct 7, 2024 57,618 $1,439,298 292,994 (+19.7%) Exercise/Conversion
    EVP Group Pres, Cardiology
    Officer
    Oct 7, 2024 132,527 $11,264,888 160,467 (-82.6%) Sale
    Chairman, President CEO
    Director, Officer
    Oct 7, 2024 55,675 $908,059 1,734,873 (+3.2%) Exercise/Conversion
    EVP Group Pres, Cardiology
    Officer
    Oct 7, 2024 59,021 $1,018,702 235,376 (+25.1%) Exercise/Conversion
    Chairman, President CEO
    Director, Officer
    Oct 7, 2024 82,085 $6,972,431 1,572,096 (-5.2%) Sale
    Chairman, President CEO
    Director, Officer
    Oct 7, 2024 80,692 $6,803,360 1,654,181 (-4.9%) Sale
    Chairman, President CEO
    Director, Officer
    Oct 7, 2024 56,211 $970,202 1,679,198 (+3.3%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Oct 1, 2024 3,066 $52,919 40,534 (+7.6%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Oct 1, 2024 6,983 $585,594 34,748 (-20.1%) Sale
    Evp, Human Resources
    Officer
    Oct 1, 2024 1,197 $29,386 41,731 (+2.9%) Exercise/Conversion
    Chairman, President CEO
    Director, Officer
    Sep 5, 2024 162,777 $13,212,544 1,622,987 (-10.0%) Sale
    Chairman, President CEO
    Director, Officer
    Sep 5, 2024 56,211 $970,202 1,730,089 (+3.2%) Exercise/Conversion
    Chairman, President CEO
    Director, Officer
    Sep 5, 2024 55,675 $908,059 1,785,764 (+3.1%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Sep 3, 2024 1,197 $29,386 44,451 (+2.7%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Sep 3, 2024 6,983 $570,511 37,468 (-18.6%) Sale
    Evp, Human Resources
    Officer
    Sep 3, 2024 3,066 $52,919 43,254 (+7.1%) Exercise/Conversion
    EVP Group Pres, Cardiology
    Officer
    Aug 28, 2024 14,132 $1,130,560 176,355 (-8.0%) Sale
    EVP Grp Pres, Medsurg Apac
    Officer
    Aug 26, 2024 1,009 $17,415 24,814 (+4.1%) Exercise/Conversion
    EVP Grp Pres, Medsurg Apac
    Officer
    Aug 26, 2024 3,176 $72,127 23,805 (+13.3%) Exercise/Conversion
    EVP Grp Pres, Medsurg Apac
    Officer
    Aug 26, 2024 14,012 $1,110,515 10,802 (-129.7%) Sale
    EVP Grp Pres, Medsurg Apac
    Officer
    Aug 6, 2024 10,843 $799,780 13,381 (-81.0%) Discretionary Transaction
    Director
    Aug 1, 2024 2,155 $161,981 2,295 (+93.9%) Grant
    Evp, Human Resources
    Officer
    Aug 1, 2024 3,066 $52,919 45,974 (+6.7%) Exercise/Conversion
    Director
    Aug 1, 2024 1,252 $94,175 3,547 (+35.3%) Grant
    Evp, Human Resources
    Officer
    Aug 1, 2024 6,983 $517,580 40,188 (-17.4%) Sale
    Evp, Human Resources
    Officer
    Aug 1, 2024 1,197 $29,386 47,171 (+2.5%) Exercise/Conversion
    Evp, Human Resources
    Officer
    Jul 1, 2024 6,983 $539,786 42,908 (-16.3%) Sale
    Evp, Human Resources
    Officer
    Jul 1, 2024 3,066 $52,919 48,694 (+6.3%) Exercise/Conversion
    Svp, Gc and Corp. Secretary
    Officer
    Jul 1, 2024 4,036 $0 36,362 (+11.1%) Exercise/Conversion
    Svp, Gc and Corp. Secretary
    Officer
    Jul 1, 2024 1,952 $149,152 34,410 (-5.7%) Payment of Exercise Price
    Evp, Human Resources
    Officer
    Jul 1, 2024 1,197 $29,386 49,891 (+2.4%) Exercise/Conversion